With oral Semaglutide, HCPs can provide robust HbA1c control to their type-II diabetes patients EP News Bureau Dec 2, 2022 Vikrant Shrotriya, MD and CVP, Novo Nordisk India, talks to Express Pharma about the potential and opportunities that the Indian…
